Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-05

Clinical Trial Update: An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism

View source ↗

Summary

An observational study completed in Japan evaluating the safety of rivaroxaban for treating venous thromboembolism in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Status: COMPLETED